News Focus
News Focus
icon url

Bruinfan4ever

08/29/17 10:43 AM

#195049 RE: MXAMDUD #195048

Of course there is no profitability. This isn't a tech stock. This is a start up biotech.

The profitability will come when a deal is made and the drugs make it to market.

He is certainly on track to do that.

icon url

TheBunny

08/29/17 11:31 AM

#195064 RE: MXAMDUD #195048

With .70's cents PS, without a sale or partnership, With failed uplist, CEO said he won't do a RS, so he locked the shareholders in a tight cage that's taking on water almost every session.

Scottsmith, who seems in close touch with leo stated:

No offers have been made for Prurisol -- that is common sense. I've counseled Leo to sell P outright in 3-6 months for whatever he can get.



So, no 'P' pending sale, and probably no Partnership either. Just more dilution that will have us into the .60's PS just around the corner.

Hope .63 holds. However, 'hope' in not a investment strategy.


he's doing neither. no profitablility, no shareholder enhancement. Just toxic financing, high overhead and shareholder losses